FAGRFagron NV
24.30EUR+1.04%Mkt Cap: 1.81B EURP/E: 19.92Last update: 2026-05-19

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compoundi…

loading…
Indicators:|

Key Statistics

Company
Market Cap1.81B EUR
Enterprise Value2.12B EUR
Revenue (TTM)952.17M EUR
Gross Profit432.00M EUR
Net Income (TTM)91.02M EUR
Revenue/Share13.03 EUR
Last Price24.30 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees4.2K
CountryBE
SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
ISINBE0003874915
Valuation
P/E (Trailing)19.92
P/E (Forward)15.19
PEG15.84
EV/EBITDA12.68
EV/Revenue2.23
P/S1.93
P/B3.32
EPS (TTM)1.24
EPS (Forward)1.65
52W Range
19.2487% of range25.05
52W High25.05 EUR
52W Low19.24 EUR
Profitability
Gross Margin45.37%
Oper. Margin15.08%
EBITDA Margin17.55%
Profit Margin9.56%
ROE16.50%
ROA7.32%
Growth
Revenue Growth7.60%
Earnings Growth12.70%
Cash Flow & Leverage
Operating CF155.25M EUR
CapEx (TTM)30.61M EUR
FCF Margin8.77%
FCF Yield4.61%
Net Debt284.23M EUR
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity0.85
Current Ratio2.11
Quick Ratio1.39
Book Value/Sh7.531 EUR
Cash/Share2.525 EUR
Dividends
Fwd Div Rate0.4000 EUR
Trail. Div Rate0.4000 EUR
Div. Yield1.62%
5Y Avg Yield1.45%
Payout Ratio28.23%
Ex-Div DateMay 18, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)28.25 EUR
Target Range27.00 EUR30.00 EUR
# Analysts6
Ownership
Shares Out.73.35M
Float65.76M
Insiders0.30%
Institutions66.32%
Technical
SMA 5023.03 (+5.5%)
SMA 20021.62 (+12.4%)
Beta0.38
S&P 52W Chg27.23%
Avg Vol (30d)129.17K
Avg Vol (10d)118.04K
Technical Indicators
RSI (14)55.2
MACD0.3196
MACD Signal0.4084
MACD Hist.-0.0888
BB Upper24.81 EUR
BB Middle24.07 EUR
BB Lower23.33 EUR
BB Width6.14%
ATR (14)0.5064 EUR
Vol Ratio (20d)1.13x